Effective Combination Immunotherapy with Oncolytic Adenovirus and Anti-PD-1 for Treatment of Human and Murine Ovarian Cancers.

Diseases · 2022 · PMC9396998 · PMID 35997357

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a slight trendno p-value reported

The combination groups and TILT-123 caused a slight trend of higher release of IFNg in 3/3 samples on both day 3 and 7 compared with the control group; however, this was not statistically significant.

also in 4,078 other papers

showed a trendno p-value reported

The measurements showed a trend that the subcutaneous tumor burden of virus and combinatorial treatment animals (anti-PD-1 and TILT-123) was reduced compared to anti-PD-1 only.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.